• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Reed E. Drews, MD


  • Warner JL, Anick P, Drews RE.Physician inter-annotator agreement in the Quality Oncology Practice Initiative manual abstraction task.J Oncol Pract. 2013 May;9(3):e96-102.
  • Drews RE.Emerging treatment options for advanced-stage mycosis fungoides.J Clin Oncol. 2012 Nov 20;30(33):4064-70.
  • Drews RE, Shulman LN.Update in hematology and oncology.Ann Intern Med. 2010 May 18;152(10):655-62. Review.
  • Roetzheim RG, Chirikos TN, Wells KJ, McCarthy EP, Ngo LH, Li D, Drews RE, Iezzoni LI.Managed care and cancer outcomes for Medicare beneficiaries with disabilities.Am J Manag Care. 2008 May;14(5):287-96.
  • Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. Review.
  • McCarthy EP, Ngo LH, Chirikos TN, Roetzheim RG, Li D, Drews RE, Iezzoni LI.Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.Health Serv Res. 2007 Apr;42(2):611-28.
  • Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS.Aggressive cutaneous T-cell lymphomas after TNFalpha blockade.J Am Acad Dermatol. 2004 Oct;51(4):660-2.
  • Kadin ME, Drews R, Samel A, Gilchrist A, Kocher O.Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.Hum Pathol. 2001 Nov;32(11):1269-72.
  • Levi E, Wang Z, Petrogiannis-Haliotis T, Pfeifer WM, Kempf W, Drews R, Kadin ME.Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression.J Invest Dermatol. 2000 Dec;115(6):1034-40.
  • Adra CN, Donato JL, Badovinac R, Syed F, Kheraj R, Cai H, Moran C, Kolker MT, Turner H, Weremowicz S, Shirakawa T, Morton CC, Schnipper LE, Drews R.SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases.Genomics. 2000 Oct 15;69(2):162-73.
  • Drews RE, Weinberger SE.Thrombocytopenic disorders in critically ill patients.Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):347-51.
  • Drews R, Samel A, Kadin ME.Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.Semin Cutan Med Surg. 2000 Jun;19(2):109-17.
  • McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J.Dying with cancer: patients' function, symptoms, and care preferences as death approaches.J Am Geriatr Soc. 2000 May;48(5 Suppl):S110-21.
  • Drews RE, Kolker MT, Sachar DS, Moran CP, Schnipper LE.Passage to nonselective media transiently alters growth of mycophenolic acid-resistant mammalian cells expressing the escherichia coli xanthine-guanine phosphoribosyltransferase gene: implications for sequential selection strategies.Anal Biochem. 1996 Mar 15;235(2):215-26.
  • Manning WJ, Goldberger AL, Drews RE, Goldstein BJ, Matheson JK, Rabinowe SL, Trentham DE, Landsberg L.POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature.Semin Arthritis Rheum. 1992 Dec;22(3):151-61.
  • Drews RE, Chan VT, Schnipper LE.Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo).Mol Cell Biol. 1992 Jan;12(1):198-206.
  • Iezzoni LI, Henderson MG, Bergman A, Drews RE.Purpose of admission and resource use during cancer hospitalizations.Health Care Financ Rev. 1991 Winter;13(2):29-40.
  • Freedman SD, Drews RE, Glotzer DJ, Kim DS, Gardner H, Galli SJ.Recurrent gastrointestinal bleeding associated with myelofibrosis and diffuse intestinal telangiectasias.Gastroenterology. 1991 Nov;101(5):1432-9.